<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01157598</url>
  </required_header>
  <id_info>
    <org_study_id>2009-08-037</org_study_id>
    <nct_id>NCT01157598</nct_id>
  </id_info>
  <brief_title>Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection</brief_title>
  <official_title>Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <brief_summary>
    <textblock>
      Background: Endoscopic submucosal dissection (ESD) usually requires adequate level of
      sedation due to lengthy and uncomfortable procedure. Propofol induced sedation with
      bispectral index (BIS) monitoring has been reported to lead to higher satisfaction of
      patients and endoscopists during ESD. However, there is no data about efficacy of midazolam
      and meperidine induced sedation with BIS monitoring during ESD. This study was to evaluate
      whether midazolam and meperidine induced sedation with BIS monitoring could improve the
      satisfaction and reduce the dose of midazolam and meperidine during ESD.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2009</start_date>
  <primary_completion_date type="Anticipated">September 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the satisfaction of patients and endoscopist in midazolam and meperidine induced sedation with BIS monitoring during ESD</measure>
    <time_frame>within the one day after ESD</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the dose of midazolam and meperidine during ESD with BIS monitoring</measure>
    <time_frame>within one hour after ESD</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Gastric Adenoma</condition>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>BIS group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>non BIS group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bispectral index monitoring</intervention_name>
    <description>parameter monitoring of bispectral index</description>
    <arm_group_label>BIS group</arm_group_label>
    <arm_group_label>non BIS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  gastric adenomas, differentiated-type gastric cancers greater than 30 mm in diameter
             without ulceration and gastric cancers up to 30 mm with ulceration, or minute
             submucosal invasion

        Exclusion Criteria:

          -  if they were under 18 years of age

          -  had an ASA classification of 4-5

          -  were pregnant

          -  had a history of stroke or an allergy to sedative drugs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jae.J Kim, professor</last_name>
    <phone>+82-2-3410-3409</phone>
    <email>jjkim@skku.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ki Joo Kang, Dr</last_name>
    <phone>+82-2-3410-3409</phone>
    <email>kj74.kang@samsung.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JaeJ Kim, professor</last_name>
      <phone>+82-2-3410-3409</phone>
      <email>jjkim@skku.edu</email>
    </contact>
    <investigator>
      <last_name>JaeJ Kim, professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2010</study_first_submitted>
  <study_first_submitted_qc>July 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2010</study_first_posted>
  <last_update_submitted>July 6, 2010</last_update_submitted>
  <last_update_submitted_qc>July 6, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2010</last_update_posted>
  <responsible_party>
    <name_title>Samsung Medical Center IRB</name_title>
    <organization>Samsung Medical Center</organization>
  </responsible_party>
  <keyword>gastric adenoma</keyword>
  <keyword>early gastric cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Meperidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

